Odyssey Therapeutics, Inc.
ODTXNASDAQHealthcareBiotechnology
Regular session
$26.6283
+$0.2383 · +0.90%
ODTX company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
38
Expensive
Momentum
42
Neutral
Sentiment
56
Mixed
Risk resilience
48
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteOdyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on discovering and developing novel treatments for autoimmune and inflammatory diseases. Its diverse pipeline features several key drug candidates: OD-001, an oral small molecule that inhibits receptor-interacting protein kinase 2, which is currently in Phase 2a clinical trials for ulcerative colitis. Also included is OD-002, an oral small molecule SLC15A4 inhibitor engineered to prevent harmful inflammatory responses driven by TLR7/8/9-mediated activation of interferon regulatory factor 5 (IRF5). Another program, OD-003, is a protein therapeutic designed to selectively agonize tumor necrosis factor receptor 2 on T regulatory cells. Further assets in its portfolio comprise a bispecific antagonist targeting TSLP and IL-33, an oral small molecule functioning as an interleukin-1 receptor-associated kinase 4 scaffolding inhibitor, and a separate small molecule inhibitor specifically targeting IRF5. The company was founded in 2021 and is headquartered in Boston, Massachusetts.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Gary D. Glick
- Listed since
- May 8, 2026
- Employees
- 100
Market position
Day range
Current $26.6283
52-week range
Current $26.6283
- Open
- $26.39
- Previous close
- $26.39
- Volume
- 18.37K
- 0.06× average
- Average volume
- 330.22K
- Average daily volume
- Market cap
- 1.28B USD
- Beta
- 1.43
- Market reference 1
- 50-day average
- $18.9332
- +40.64% above average
- 200-day average
- $18.3829
- +44.85% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 437.98M USD
- P/E (TTM)
- -4.94×
- P/B (TTM)
- -1.5×
- P/S (TTM)
- 429.77×
- EV / EBITDA
- -3.03×
- Earnings yield
- -32.85%
- Free cash flow yield
- -28.88%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 100.00%
- Operating margin
- -5415.19%
- Net margin
- -4994.86%
- Return on equity
- 30.44%
- Return on assets
- -55.10%
- Return on invested capital
- -64.44%
Financial health
- Debt / equity
- -0.06×
- Current ratio
- 7.2×
Financial statements
| Metric (USD) | FY2025 |
|---|---|
| Revenue | 2.98M USD |
| Gross profit | 2.98M USD |
| Research and development | 126.62M USD |
| Selling, general, and administrative | 37.52M USD |
| Operating expenses | 164.13M USD |
| Interest income | 6.35M USD |
| Interest expense | 17K USD |
| Depreciation and amortization | 4.91M USD |
| Operating income | −161.16M USD |
| Net income | −148.65M USD |
Company facts updated Aug 24, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Recent analyst actions
ODTX news
ODTX peers
ETFs holding ODTX
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI10.05M0.00%2.3T USD0.03%$377.26-0.26%
Vanguard Extended Market ETFVXF3.4M0.00%93.7B USD0.05%$244.04-0.61%
Schwab U.S. Small-Cap ETFSCHA1.94M0.01%23.1B USD0.03%$34.47-1.05%
Schwab U.S. Broad Market ETFSCHB312.88K0.00%44.6B USD0.03%$29.525-0.29%
Vanguard Russell 2000 ETFVTWO224.95K0.00%17.4B USD0.06%$120.79-0.38%
Vanguard Russell 2000 Growth ETFVTWG22.13K0.00%1.7B USD0.06%$280.38-0.83%
Vanguard Russell 2000 Value ETFVTWV8.29K0.00%1.4B USD0.06%$198.48+0.05%
Vanguard Russell 3000 ETFVTHR3.69K0.00%6.1B USD0.06%$338.04-0.26%Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 10.05M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $377.26-0.26%
Vanguard Extended Market ETFVXF- Market value
- 3.4M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $244.04-0.61%
Schwab U.S. Small-Cap ETFSCHA- Market value
- 1.94M
- Weight
- 0.01%
- AUM
- 23.1B USD
- Expense ratio
- 0.03%
- Price / 1D
- $34.47-1.05%
Schwab U.S. Broad Market ETFSCHB- Market value
- 312.88K
- Weight
- 0.00%
- AUM
- 44.6B USD
- Expense ratio
- 0.03%
- Price / 1D
- $29.525-0.29%
Vanguard Russell 2000 ETFVTWO- Market value
- 224.95K
- Weight
- 0.00%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $120.79-0.38%
Vanguard Russell 2000 Growth ETFVTWG- Market value
- 22.13K
- Weight
- 0.00%
- AUM
- 1.7B USD
- Expense ratio
- 0.06%
- Price / 1D
- $280.38-0.83%
Vanguard Russell 2000 Value ETFVTWV- Market value
- 8.29K
- Weight
- 0.00%
- AUM
- 1.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $198.48+0.05%
Vanguard Russell 3000 ETFVTHR- Market value
- 3.69K
- Weight
- 0.00%
- AUM
- 6.1B USD
- Expense ratio
- 0.06%
- Price / 1D
- $338.04-0.26%
Continue in GoAI
Research ODTXresearch.disclaimer